15 insiders reported 46 Form 4 transactions for SOLENO THERAPEUTICS INC (SLNO) over the past 18 months (most recent 2026-05-18). Recent activity: Huang Michael F. (Sr. VP of Clinical Development) Sell 39,823 shares, Volck Birgitte (Director) Sell 17,536 shares, Yen Kristen (Officer title: SVP Global Clinical Operations and Patient Advocacy) Sell 37,639 shares, Sinclair Andrew (Director) Sell 10,491 shares, Norrett Kevin (Chief Business Officer) Sell 17,786 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 39,823 | $0 |
| 2026-05-18 | Volck Birgitte | Director | Sell | 17,536 | $0 |
| 2026-05-18 | Yen Kristen | Officer title: SVP Global Clinical Operations and Patient Advocacy | Sell | 37,639 | $0 |
| 2026-05-18 | Sinclair Andrew | Director | Sell | 10,491 | $0 |
| 2026-05-18 | Norrett Kevin | Chief Business Officer | Sell | 17,786 | $0 |
| 2026-05-18 | Hahn Mark W | Director | Sell | 10,046 | $0 |
| 2026-05-18 | Joshi Manher | Chief Development Officer | Sell | 20,171 | $0 |
| 2026-05-18 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | Sell | 39,200 | $0 |
| 2026-05-18 | Pauls Matthew | Director | Sell | 10,491 | $0 |
| 2026-05-18 | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Sell | 583,656 | $0 |
| 2026-05-18 | Hirano Patricia C | Officer title: Senior Vice President, Regulatory Affairs | Sell | 22,702 | $0 |
| 2026-05-18 | Manning Meredith | Chief Commercial Officer | Sell | 64,507 | $0 |
| 2026-05-18 | Bir Dawn Carter | Director | Sell | 16,991 | $0 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 4,256 | $127,850 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 1,838 | $57,052 |
| 2026-03-31 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 488 | $15,479 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | Sell | 4,864 | $146,115 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | Sell | 2,100 | $65,184 |
| 2026-03-31 | Manning Meredith | Chief Commercial Officer | Sell | 558 | $17,700 |
| 2026-03-04 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | Buy | 39,200 | $0 |
| 2026-01-23 | Huang Michael F. | Sr. VP of Clinical Development | Buy | 10,400 | $0 |
| 2026-01-23 | Joshi Manher | Chief Development Officer | Buy | 4,100 | $0 |
| 2026-01-23 | Mackaness James H | CHIEF FINANCIAL OFFICER | Buy | 28,600 | $0 |
| 2026-01-23 | Hirano Patricia C | Officer title: Senior Vice President, Regulatory Affairs | Buy | 10,400 | $0 |
| 2026-01-23 | Anish Bhatnagar | CHIEF EXECUTIVE OFFICER | Buy | 114,200 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18